American drug policy is the intersection of public health, criminal justice, and racial politics in its most contested and least rational form.
The Architecture's Logic
The American drug policy architecture — the combination of federal and state drug scheduling, criminal penalties for possession and distribution, enforcement priorities, treatment infrastructure, and harm reduction programmes — is the product of a half-century of policy accumulation that has produced an approach to drug use that is simultaneously more punitive and less effective than the approaches of most comparable countries. The Controlled Substances Act's scheduling framework classifies drugs according to categories that reflect the political context of their creation rather than current pharmacological and public health evidence: cannabis remains a Schedule I substance with no accepted medical use in the federal framework despite strong evidence for medical applications and the legal cannabis programmes of more than half of US states. And the criminal penalties for drug possession have been used disproportionately against Black and Latino communities despite similar drug use rates across racial groups.
The public health dimension of drug policy — the treatment infrastructure, the harm reduction programmes, the overdose response — has been chronically underfunded relative to the enforcement dimension, producing the specific outcomes that the funding allocation would predict: inadequate treatment access for people with substance use disorders, insufficient harm reduction infrastructure to address the overdose crisis, and the incarceration of people whose primary need is treatment rather than punishment.
American drug policy reflects the governance choices made when the political salience of appearing tough on drugs exceeded the policy salience of actually addressing the harms that drug use causes. The overdose crisis — which killed more Americans in 2023 than any year in American history — is the accumulated public health cost of fifty years of drug policy that prioritised criminal punishment over public health treatment. Changing it requires the political will to acknowledge that the approach has failed.
Discussion